The DOI matches its Crossref record; 149 of the 149 references it cites were found in a registry or an index.
Biofilm infections, their resilience to therapy and innovative treatment strategies
Open accessAbstract
Biofilm formation of microorganisms causes persistent tissue and foreign body infections resistant to treatment with antimicrobial agents. Up to 80% of human bacterial infections are biofilm associated; such infections are most frequently caused byS taphylococcus epidermidis,P seudomonas aeruginosa,S taphylococcus aureus and E nterobacteria such asE scherichia coli. The accurate diagnosis of biofilm infections is often difficult, which prevents the appropriate choice of treatment. As biofilm infections significantly contribute to patient morbidity and substantial healthcare costs, novel strategies to treat these infections are urgently required. Nucleotide second messengers, c‐di‐GMP, (p)pp G pp and potentially c‐di‐AMP, are major regulators of biofilm formation and associated antibiotic tolerance. Consequently, different components of these signalling networks might be appropriate targets for antibiofilm therapy in combination with antibiotic treatment strategies. In addition, cyclic di‐nucleotides are microbial‐associated molecular patterns with an almost universal presence. Their conserved structures sensed by the eukaryotic host have a widespread effect on the immune system. Thus, cyclic di‐nucleotides are also potential immunotherapeutic agents to treat antibiotic‐resistant bacterial infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
RETRACTED: Bacterial persistence by RNA endonucleases
Maisonneuve, E., Shakespeare, L. J., Jørgensen, M. G., & Gerdes, K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100186108 · Cited by 475
RetractedRETRACTED: A Self-Produced Trigger for Biofilm Disassembly that Targets Exopolysaccharide
Kolodkin-Gal, I., Cao, S., Chai, L., Böttcher, T., Kolter, R., Clardy, J., & Losick, R. (2012) · Cell · doi:10.1016/j.cell.2012.02.055 · Cited by 159
RetractedBacterial Biofilms: A Common Cause of Persistent Infections
Costerton, J. W., Stewart, P. S., & Greenberg, E. P. (1999) · Science · doi:10.1126/science.284.5418.1318 · Cited by 12,167
Biofilm formation as microbial development
O'Toole, G., Kaplan, H. B., & Kolter, R. (2000) · Annual Review of Microbiology · doi:10.1146/annurev.micro.54.1.49 · Cited by 3,571
How antibiotics kill bacteria: from targets to networks
Kohanski, M. A., Dwyer, D. J., & Collins, J. J. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2333 · Cited by 2,258
Lewis, K. (2010) · Annual Review of Microbiology · doi:10.1146/annurev.micro.112408.134306 · Cited by 1,858
STING is a direct innate immune sensor of cyclic di-GMP
Burdette, D. L., Monroe, K. M., Sotelo-Troha, K., Iwig, J. S., Eckert, B., Hyodo, M., Hayakawa, Y., & Vance, R. E. (2011) · Nature · doi:10.1038/nature10429 · Cited by 1,570
Bacterial Biofilms: An Emerging Link to Disease Pathogenesis
Parsek, M. R., & Singh, P. K. (2003) · Annual Review of Microbiology · doi:10.1146/annurev.micro.57.030502.090720 · Cited by 1,562
Aminoglycoside antibiotics induce bacterial biofilm formation
Hoffman, L. R., D'Argenio, D. A., MacCoss, M. J., Zhang, Z., Jones, R. A., & Miller, S. I. (2005) · Nature · doi:10.1038/nature03912 · Cited by 1,321
Cellulose biosynthesis and function in bacteria
Ross, P., Mayer, R., & Benziman, M. (1991) · Microbiological Reviews · doi:10.1128/mr.55.1.35-58.1991 · Cited by 1,248
Cited by
Cyclic di-GMP: the First 25 Years of a Universal Bacterial Second Messenger
Römling, U., Galperin, M. Y., & Gomelsky, M. (2013) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00043-12 · Cited by 1,700
Self-citationPseudomonas aeruginosa Lifestyle: A Paradigm for Adaptation, Survival, and Persistence
Moradali, M. F., Ghods, S., & Rehm, B. H. A. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00039 · Cited by 1,537
Pseudomonas aeruginosa Biofilms
Thi, M. T. T., Wibowo, D., & Rehm, B. H. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228671 · Cited by 911
de la Fuente-Núñez, C., Reffuveille, F., Fernández, L., & Hancock, R. E. (2013) · Current Opinion in Microbiology · doi:10.1016/j.mib.2013.06.013 · Cited by 801
Nitric Oxide Therapy for Diabetic Wound Healing
Malone‐Povolny, M. J., Maloney, S. E., & Schoenfisch, M. H. (2019) · Advanced Healthcare Materials · doi:10.1002/adhm.201801210 · Cited by 498
Novel Strategies for the Prevention and Treatment of Biofilm Related Infections
Chen, M., Yu, Q., & Sun, H. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140918488 · Cited by 429
Mechanisms of Candida Biofilm Drug Resistance
Taff, H. T., Mitchell, K. F., Edward, J. A., & Andes, D. R. (2013) · Future Microbiology · doi:10.2217/fmb.13.101 · Cited by 422
Challenges of intervention, treatment, and antibiotic resistance of biofilm-forming microorganisms
Gebreyohannes, G., Nyerere, A., Bii, C., & Sbhatu, D. B. (2019) · Heliyon · doi:10.1016/j.heliyon.2019.e02192 · Cited by 414
Pseudomonas aeruginosa Biofilms: Host Response and Clinical Implications in Lung Infections
Maurice, N. M., Bedi, B., & Sadikot, R. T. (2018) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2017-0321tr · Cited by 373
Programmable biofilm-based materials from engineered curli nanofibres
Nguyen, P. Q., Botyanszki, Z., Tay, P. K. R., & Joshi, N. S. (2014) · Nature Communications · doi:10.1038/ncomms5945 · Cited by 366
Approaches to Dispersing Medical Biofilms
Fleming, D., & Rumbaugh, K. (2017) · Microorganisms · doi:10.3390/microorganisms5020015 · Cited by 329
Action of Antimicrobial Peptides against Bacterial Biofilms
Yasir, M., Willcox, M. D. P., & Dutta, D. (2018) · Materials · doi:10.3390/ma11122468 · Cited by 319
Liao, C., Huang, X., Wang, Q., Yao, D., & Lu, W. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.926758 · Cited by 309
Li, M., Li, L., Su, K., Liu, X., Zhang, T., Liang, Y., Jing, D., Yang, X., Zheng, D., Cui, Z., et al. (2019) · Advanced Science · doi:10.1002/advs.201900599 · Cited by 305
Microtiter plate assays to assess antibiofilm activity against bacteria
Haney, E. F., Trimble, M. J., & Hancock, R. E. W. (2021) · Nature Protocols · doi:10.1038/s41596-021-00515-3 · Cited by 295
Biofilm formation to inhibition: Role of zinc oxide-based nanoparticles
Mahamuni-Badiger, P. P., Patil, P. M., Badiger, M. V., Patel, P. R., Thorat- Gadgil, B. S., Pandit, A., & Bohara, R. A. (2020) · Materials Science and Engineering: C · doi:10.1016/j.msec.2019.110319 · Cited by 264
Antimicrobial peptides – Advances in development of therapeutic applications
Luong, H. X., Thanh, T. T., & Tran, T. H. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118407 · Cited by 258
Nitric oxide–releasing macromolecular scaffolds for antibacterial applications
Yang, L., Feura, E. S., Ahonen, M. J. R., & Schoenfisch, M. H. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201800155 · Cited by 218
Engineered microbial consortia: strategies and applications
Duncker, K. E., Holmes, Z. A., & You, L. (2021) · Microbial Cell Factories · doi:10.1186/s12934-021-01699-9 · Cited by 196
Biofilm and wound healing: from bench to bedside
Goswami, A. G., Basu, S., Banerjee, T., & Shukla, V. K. (2023) · European Journal of Medical Research · doi:10.1186/s40001-023-01121-7 · Cited by 178
Genetic control of bacterial biofilms
Wolska, K. I., Grudniak, A. M., Rudnicka, Z., & Markowska, K. (2016) · Journal of Applied Genetics · doi:10.1007/s13353-015-0309-2 · Cited by 154
Brockson, M. E., Novotny, L. A., Mokrzan, E. M., Malhotra, S., Jurcisek, J. A., Akbar, R., Devaraj, A., Goodman, S. D., & Bakaletz, L. O. (2014) · Molecular Microbiology · doi:10.1111/mmi.12735 · Cited by 81
Imaging biofilms using fluorescence in situ hybridization: seeing is believing
Barbosa, A., Miranda, S., Azevedo, N. F., Cerqueira, L., & Azevedo, A. S. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1195803 · Cited by 63
Lactobacillus plantarum Lipoteichoic Acid Inhibits Oral Multispecies Biofilm
Kim, A. R., Ahn, K. B., Yun, C.-H., Park, O.-J., Perinpanayagam, H., Yoo, Y.-J., Kum, K.-Y., & Han, S. H. (2019) · Journal of Endodontics · doi:10.1016/j.joen.2018.12.007 · Cited by 56
Andrés-Lasheras, S., Jelinski, M., Zaheer, R., & McAllister, T. A. (2022) · Antibiotics · doi:10.3390/antibiotics11040487 · Cited by 42
Role of biofilms in antimicrobial resistance of the bacterial bovine respiratory disease complex
Andrés-Lasheras, S., Zaheer, R., Jelinski, M., & McAllister, T. A. (2024) · Frontiers in Veterinary Science · doi:10.3389/fvets.2024.1353551 · Cited by 15
Metadata
- Authors
- Römling, U., & Balsalobre, C.
- Venue
- Journal of Internal Medicine
- Publisher
- Wiley
- Published
- 2012-10-29
- Volume
- 272
- Issue
- 6
- Pages
- 541-561
- ISSN
- 0954-6820 (ISSN-L)
- 1365-2796
- OpenAlex
- W1989942811
- Cited by
- 865
- References
- 149
- FWCI
- 12.43
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.